GlassScriptPhysician profile
John L Damiani
NPI 1578534384
$1,816.80
in general payments reported to CMS, 2019-2025
30 companies · $322 in 2025
The $322 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $115 · 2020: $37.59 · 2021: $326 · 2022: $230 · 2023: $381 · 2024: $405 · 2025: $322.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,108.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,107.64 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $222.79 | 2019-2024 | Xtandi |
| Procept Biorobotics Corporation | $215.77 | 2022-2024 | Aquabeam System |
| 180 Medical, INC. | $214.26 | 2021-2024 | Cure Catheter |
| Abbvie INC. | $157.68 | 2021-2025 | Lupron Depot |
| Antares Pharma, INC. | $120.04 | 2022-2025 | Xyosted, Nocdurna, Tlando |
| Janssen Biotech, INC. | $97.83 | 2019-2025 | Erleada |
| Urogen Pharma, INC. | $76.57 | 2021-2025 | Jelmyto |
| Tolmar, INC. | $60.57 | 2023-2025 | Jatenzo, Eligard |
| Sumitomo Pharma America, INC. | $59.11 | 2023-2024 | Gemtesa |
| Convatec INC. | $49.71 | 2023-2024 | |
| Urovant Sciences INC | $46.13 | 2021-2022 | |
| Blue Earth Diagnostics | $42.90 | 2019-2020 | |
| Progenics Pharmaceuticals, INC. | $42.60 | 2024-2025 | |
| Teleflex LLC | $36.04 | 2021 | |
| Laborie Medical Technologies Corp. | $35.33 | 2022-2025 |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Myovant Sciences INC. | $35.00 | 2021-2022 | |
| Pfizer INC. | $33.45 | 2020-2025 | |
| Boston Scientific Corporation | $32.37 | 2019-2023 | Rezum Generator |
| Coloplast Corp | $31.37 | 2022-2023 | Saffron |
| Merck Sharp & Dohme LLC | $30.34 | 2024 | Keytruda |
| Caldera Medical, INC | $28.98 | 2023 | Desara |
| Myriad Genetic Laboratories, INC. | $28.82 | 2023 | Prolaris |
| Verity Pharmaceuticals INC. | $23.33 | 2025 | Trelstar |
| Avation Medical, INC. | $19.02 | 2025 | Vivally System |
| Endo Pharmaceuticals INC. | $14.15 | 2019 | |
| Amgen INC. | $13.99 | 2023 | Prolia |
| Cook Medical LLC | $13.77 | 2022 | |
| Olympus America INC. | $13.70 | 2022 | |
| Allergan, INC. | $12.44 | 2021 | |
| Ambu INC. | $8.74 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Damiani listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.